- Home
- CASI vs OPI Comparison
CASI vs OPI Comparison
Compare CASI & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- OPI
- Stock Information
- Founded
- CASI 1991
- OPI 2009
- Country
- CASI China
- OPI United States
- Employees
- CASI N/A
- OPI N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- OPI Real Estate Investment Trusts
- Sector
- CASI Health Care
- OPI Real Estate
- Exchange
- CASI Nasdaq
- OPI Nasdaq
- Market Cap
- CASI 35.8M
- OPI 40.8M
- IPO Year
- CASI 1996
- OPI 2009
- Fundamental
- Price
- CASI $1.84
- OPI $0.20
- Analyst Decision
- CASI Strong Buy
- OPI
- Analyst Count
- CASI 1
- OPI 0
- Target Price
- CASI $4.00
- OPI N/A
- AVG Volume (30 Days)
- CASI 305.0K
- OPI 36.9M
- Earning Date
- CASI 11-13-2025
- OPI 10-29-2025
- Dividend Yield
- CASI N/A
- OPI 15.00%
- EPS Growth
- CASI N/A
- OPI N/A
- EPS
- CASI N/A
- OPI N/A
- Revenue
- CASI $31,564,000.00
- OPI $466,972,000.00
- Revenue This Year
- CASI N/A
- OPI N/A
- Revenue Next Year
- CASI N/A
- OPI N/A
- P/E Ratio
- CASI N/A
- OPI N/A
- Revenue Growth
- CASI 36.64
- OPI N/A
- 52 Week Low
- CASI $1.09
- OPI $0.18
- 52 Week High
- CASI $7.50
- OPI $2.14
- Technical
- Relative Strength Index (RSI)
- CASI 51.04
- OPI 39.01
- Support Level
- CASI $1.77
- OPI $0.21
- Resistance Level
- CASI $2.08
- OPI $0.48
- Average True Range (ATR)
- CASI 0.20
- OPI 0.08
- MACD
- CASI 0.02
- OPI -0.03
- Stochastic Oscillator
- CASI 71.84
- OPI 0.00
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.